Increasing SMN levels using the histone deacetylase inhibitor SAHA ameliorates defects in skeletal muscle microvasculature in a mouse model of severe spinal muscular atrophy

Eilidh Somers, Markus Riessland, Julia Schreml, Brunhilde Wirth, Thomas H Gillingwater, Simon H Parson

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Increasing SMN levels using the histone deacetylase inhibitor SAHA ameliorates defects in skeletal muscle microvasculature in a mouse model of severe spinal muscular atrophy'. Together they form a unique fingerprint.

Medicine & Life Sciences